A Phase III, Randomized, Double-blind, Placebo-controlled Study of SHR0410 Injection for the Treatment of Pain After Laparoscopic Surgery
Latest Information Update: 06 Jun 2024
At a glance
- Drugs SHR-0410 (Primary)
- Indications Postoperative pain
- Focus Registrational; Therapeutic Use
- Sponsors Jiangsu Hengrui Medicine Co.
Most Recent Events
- 18 Jul 2022 New trial record